Are Germany and Italy standing in the way of progress in European stem cell research?

A report published last week from the European Science federation (ESF) has given 27 different countries one of four possible statuses based on the permissiveness of their stem cell policies. With the possibility of being deemed either very permissive with regards to human Embryonic Stem Cells, permissive with restrictions, restrictive by default, or very restrictive, the authors of the paper, …

Adult stem cells isolated from human intestinal tissue for the first time

Researchers at the University of North Carolina have for the first time isolated adult stem cells from human intestinal tissue. The research, published in the journal Stem Cells, represents a major step forward in stem cell research because previous studies have relied on isolating intestinal epithelial stem cells (IESCs) from mice and as such have limited direct clinical relevance. “While …

The move from big pharma to stem cells is underway as Shire makes a $200M deal to purchase Pervasis

FierceBiotech recently reported that Shire is buying the biotech Pervasis Therapeutics with an eye toward boosting its regenerative medicine unit, adding the small company’s cellular therapy in mid-stage development for vascular repair in patients on hemodialysis. The buyout follows Shire’s purchase of Advanced BioHealing last year in a deal that created the business that specializes in cell-based therapies. Ireland-based Shire …

Breakthrough in Stem cell research

Fiercebiotech recently reported that: Stem cell research is making significant strides so far this year, advancing in often-unexpected directions. The Wall Street Journal reported one of the more interesting developments just last week: Yale University doctors were able to treat a 4-year-old girl’s heart defect by implanting a biodegradable scaffolding covered with the patient’s bone marrow cells. Six months after …